[go: up one dir, main page]

PL3325443T3 - Sposób otrzymywania pridopidyny - Google Patents

Sposób otrzymywania pridopidyny

Info

Publication number
PL3325443T3
PL3325443T3 PL16828644.1T PL16828644T PL3325443T3 PL 3325443 T3 PL3325443 T3 PL 3325443T3 PL 16828644 T PL16828644 T PL 16828644T PL 3325443 T3 PL3325443 T3 PL 3325443T3
Authority
PL
Poland
Prior art keywords
pridopidine
preparing
preparing pridopidine
Prior art date
Application number
PL16828644.1T
Other languages
English (en)
Inventor
Offir BAREL
Ramy Lidor-Hadas
Ronen Gottesfeld
Orel Yosef Mizrahi
Anders Olof Ingemar Bergh
Ba-Vu Nguyen
Original Assignee
Prilenia Neurotherapeutics Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prilenia Neurotherapeutics Ltd. filed Critical Prilenia Neurotherapeutics Ltd.
Publication of PL3325443T3 publication Critical patent/PL3325443T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
PL16828644.1T 2015-07-22 2016-07-22 Sposób otrzymywania pridopidyny PL3325443T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562195756P 2015-07-22 2015-07-22
PCT/US2016/043682 WO2017015609A1 (en) 2015-07-22 2016-07-22 Process for preparing pridopidine

Publications (1)

Publication Number Publication Date
PL3325443T3 true PL3325443T3 (pl) 2022-08-01

Family

ID=57834816

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16828644.1T PL3325443T3 (pl) 2015-07-22 2016-07-22 Sposób otrzymywania pridopidyny

Country Status (10)

Country Link
US (1) US10047049B2 (pl)
EP (1) EP3325443B1 (pl)
AR (1) AR105434A1 (pl)
CA (1) CA2993607C (pl)
DK (1) DK3325443T3 (pl)
ES (1) ES2922991T3 (pl)
HU (1) HUE059158T2 (pl)
PL (1) PL3325443T3 (pl)
TW (1) TW201718491A (pl)
WO (1) WO2017015609A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140008297A (ko) 2010-09-03 2014-01-21 아이백스 인터내셔널 게엠베하 도파민성 안정제로서 유용한 프리도피딘의 듀테륨화된 유사체
TWI579272B (zh) 2011-12-08 2017-04-21 梯瓦製藥國際有限責任公司 普多比啶(pridopidine)之氫溴酸鹽
CN105592848A (zh) 2013-06-21 2016-05-18 梯瓦制药国际有限责任公司 高剂量普利多匹定用于治疗亨廷顿舞蹈症的用途
US11090297B2 (en) 2013-06-21 2021-08-17 Prilenia Neurotherapeutics Ltd. Pridopidine for treating huntington's disease
TW201613859A (en) 2014-06-30 2016-04-16 Teva Pharma Analogs of PRIDOPIDINE, their preparation and use
US9907786B2 (en) * 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US11471449B2 (en) 2015-02-25 2022-10-18 Prilenia Neurotherapeutics Ltd. Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
DK3261721T3 (da) 2015-02-25 2022-11-28 Prilenia Neurotherapeutics Ltd Anvendelse af pridopidin til forbedring af hukommelse
JP7034488B2 (ja) 2016-02-24 2022-03-14 プリレニア・ニューロセラピューティクス・エルティーディー プリドピジンを使用する神経変性眼疾患の治療
CN109923102B (zh) 2016-08-24 2022-11-15 普瑞尼亚神经治疗有限公司 普利多匹定用于治疗功能下降的用途
WO2018039475A1 (en) 2016-08-24 2018-03-01 Teva Pharmaceuticals International Gmbh Use of pridopidine for treating dystonias
US12102627B2 (en) 2016-09-16 2024-10-01 Prilenia Neurotherapeutics Ltd. Use of pridopidine for treating rett syndrome
EP3357909A1 (en) * 2017-02-02 2018-08-08 Sandoz AG Crystalline 4-[3-(methylsulfonyl)phenyl]-1-propyl-piperidine
BR112020003119A2 (pt) 2017-08-14 2020-10-13 Prilenia Neurotherapeutics Ltd. método de tratamento de esclerose lateral amiotrófica com pridopidina
EP3675830A1 (en) 2017-08-30 2020-07-08 Prilenia Neurotherapeutics Ltd. High concentration dosage forms of pridopidine
US12036213B2 (en) 2017-09-08 2024-07-16 Prilenia Neurotherapeutics Ltd. Pridopidine for treating drug induced dyskinesias
BR112020004622A2 (pt) 2017-09-08 2020-09-24 Prilenia Neurotherapeutics Ltd. pridopidina para tratamento de discinesias induzidas por droga
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof
CN119137100A (zh) * 2022-05-03 2024-12-13 普瑞尼亚神经治疗有限公司 用于制备普利多匹定的工艺和中间体

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641320B1 (en) 1991-04-17 2001-05-30 PHARMACIA & UPJOHN COMPANY Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists
SE9702716D0 (sv) 1997-07-15 1997-07-15 Ross Nicholas Waters Substituted phenylazacycloalkanes in the treatment of cognitive disorders
SE9904724D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
JP4891908B2 (ja) * 2004-10-13 2012-03-07 エヌエスエービー,フィリアル アフ ニューロサーチ スウェーデン アクチボラゲット,スヴェリエ 4−(3−メタンスルホニルフェニル)−1−n−プロピルピペリジンの合成方法
EP1807394A1 (en) 2004-10-13 2007-07-18 Neurosearch Sweden AB Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines
CA2683719C (en) 2007-04-12 2015-07-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
WO2011107583A1 (en) * 2010-03-04 2011-09-09 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders
KR20140008297A (ko) * 2010-09-03 2014-01-21 아이백스 인터내셔널 게엠베하 도파민성 안정제로서 유용한 프리도피딘의 듀테륨화된 유사체
CN103958469B (zh) * 2011-09-07 2016-04-20 梯瓦制药国际有限责任公司 一种新的普利多匹定盐酸盐多晶型形态
TWI579272B (zh) * 2011-12-08 2017-04-21 梯瓦製藥國際有限責任公司 普多比啶(pridopidine)之氫溴酸鹽
BR112014024672A8 (pt) 2012-04-04 2018-04-03 Ivax Int Gmbh Composições farmacêuticas para terapia de combinação
AU2013323131A1 (en) 2012-09-27 2015-05-07 Teva Pharmaceutical Industries Ltd. Laquinimod and pridopidine for treating neurodegenerative disorders
MX2015003812A (es) 2012-09-27 2015-07-17 Teva Pharma Combinacion de rasagilina y pridopidina para tratar trastornos neurodegenerativos, en particular enfermedad de huntington.
CN105592848A (zh) 2013-06-21 2016-05-18 梯瓦制药国际有限责任公司 高剂量普利多匹定用于治疗亨廷顿舞蹈症的用途
MX2016009427A (es) 2014-01-22 2016-12-08 Teva Pharmaceuticals Int Gmbh Formulaciones de pridopidina de liberacion modificada.
TW201613859A (en) 2014-06-30 2016-04-16 Teva Pharma Analogs of PRIDOPIDINE, their preparation and use
EP3236964A4 (en) 2014-12-22 2018-09-19 Teva Pharmaceuticals International GmbH L-tartrate salt of pridopidine
DK3261721T3 (da) 2015-02-25 2022-11-28 Prilenia Neurotherapeutics Ltd Anvendelse af pridopidin til forbedring af hukommelse
WO2016138135A1 (en) 2015-02-25 2016-09-01 Teva Pharmaceuticals International Gmbh Sigma-1 receptor modulators for treating huntington's disease
CA2993183A1 (en) 2015-07-22 2017-01-26 Teva Pharmaceuticals International Gmbh Pridopidine base formulations and their use

Also Published As

Publication number Publication date
AR105434A1 (es) 2017-10-04
EP3325443B1 (en) 2022-06-08
WO2017015609A1 (en) 2017-01-26
EP3325443A4 (en) 2019-01-16
CA2993607A1 (en) 2017-01-26
TW201718491A (zh) 2017-06-01
DK3325443T3 (da) 2022-07-18
CA2993607C (en) 2024-01-16
US10047049B2 (en) 2018-08-14
ES2922991T3 (es) 2022-09-22
HUE059158T2 (hu) 2022-10-28
EP3325443A1 (en) 2018-05-30
US20170022158A1 (en) 2017-01-26

Similar Documents

Publication Publication Date Title
ZA201708142B (en) Process for preparing 4-amino-pyridazines
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
IL249730B (en) A process for the preparation of pyrazoles
IL274439A (en) Process for making Tapinaroff
PT3196196T (pt) Método para a preparação de calcobutrol
PL3371150T3 (pl) Sposób wytwarzania briwaracetamu
HK1247097A1 (zh) 用於製備氟酮內酯的方法
IL253877B (en) Process for the preparation of 3-chloro-2-vinylphenylsulfonates
PL3160984T3 (pl) Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylol- fenyloalaninoamidu
ZA201908452B (en) Improved process for preparing imetelstat
GB2536979B (en) Process for preparing boscalid
PL3156381T3 (pl) Sposób wytwarzania granulek
IL249283B (en) Process for the preparation of 3-chloro-2-vinylphenol
GB2539022B (en) Process for preparing boscalid
PL3113919T3 (pl) Sposób powlekania fragmentu powierzchni
ZA201807441B (en) Process for preparing oxathiazin-like compounds
ZA201803631B (en) Improved process for making crotonylaminopyridines
IL253630B (en) A process for the preparation of modified phenylisoxazoline derivatives
IL253830B (en) Process for the preparation of piperidine-4-carbothioamide hydrochloride
SG11201709830YA (en) Process for preparing carbazoles